Please assess the completion status of the following clinical trial:

Trial Title: Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: None
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Histologically confirmed primary squamous, basaloid, or cloacogenic carcinoma of the anal canal, other than carcinoma in situ~  * T2-4, Any N, M0 (stage II or III)~* No local or regional recurrence after local excision or abdominal peritoneal resection~PATIENT CHARACTERISTICS:~Age:~* 18 and over~Performance status:~* Karnofsky 60-100%~Life expectancy:~* Not specified~Hematopoietic:~* WBC at least 4,000/mm\^3~* Absolute neutrophil count at least 1,800/mm\^3~* Platelet count at least 100,000/mm\^3~* Hemoglobin at least 10 g/dL~Hepatic:~* Bilirubin less than 1.4 mg/dL~Renal:~* Creatinine no greater than 1.5 mg/dL OR~* Creatinine clearance at least 80 mL/min~Cardiovascular:~* No uncompensated heart disease~* No uncontrolled high blood pressure~Other:~* No AIDS~* No active systemic infection~* No uncontrolled diabetes~* No other prior malignancy within the past 5 years except nonmelanoma skin cancer~* No mental condition that would preclude study participation~* Not pregnant or nursing~* Fertile patients must use effective contraception~PRIOR CONCURRENT THERAPY:~Biologic therapy:~* Prior epoetin alfa allowed in lieu of blood transfusions~Chemotherapy:~* At least 5 years since prior chemotherapy~Endocrine therapy:~* Not specified~Radiotherapy:~* At least 5 years since prior radiotherapy~Surgery:~* No prior surgery of anal canal except for biopsy of study site

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 120 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).